RAPT Company Profile and Key Details
RAPT Therapeutics, Inc.
RAPT Stock Price Chart
Stock Price Today
RAPT Therapeutics, Inc. (RAPT) stock surged +1.67%, trading at $1.22 on NASDAQ, up from the previous close of $1.20. The stock opened at $1.20, fluctuating between $1.17 and $1.28 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Company Information
| Employees | 70 |
| Beta | 0.32 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
RAPT Therapeutics, Inc. (NASDAQ: RAPT) stock price is $1.22 in the last trading session. During the trading session, RAPT stock reached the peak price of $1.28 while $1.17 was the lowest point it dropped to. The percentage change in RAPT stock occurred in the recent session was 1.67% while the dollar amount for the price change in RAPT stock was $0.02.
The NASDAQ listed RAPT is part of Biotechnology industry that operates in the broader Healthcare sector. RAPT Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Jennifer Nicholson
Senior Vice President of Regulatory Affairs & Quality Assurance
Ms. Gwen R. Carscadden
Chief HR Officer
Dr. William Ho
Chief Medical Officer
Dr. David Wustrow
Senior Vice President of Drug Discovery & Preclinical Devel.
Dr. Dirk G. Brockstedt Ph.D.
Chief Scientific Officer
Dr. Brian Russell Wong M.D., Ph.D.
Chief Executive Officer, Pres & Director
Steve Young Ph.D.
Vice President of Technology
Dr. Paul Kassner
Senior Vice President of Quantitative & Computational Biology
Mr. Rodney K. B. Young
Chief Financial Officer, Principal Accounting Officer & Sec.
Mr. Michael Listgarten
Gen. Counsel
RAPT's closing price is 54.63% higher than its 52-week low of $0.79 where as its distance from 52-week high of $27.35 is -95.54%.
Number of RAPT employees currently stands at 70.
Official Website of RAPT is: https://www.rapt.com
RAPT could be contacted at phone 650 489 9000 and can also be accessed through its website. RAPT operates from 561 Eccles Avenue, South San Francisco, CA 94080, United States.
RAPT stock volume for the day was 718.88K shares. The average number of RAPT shares traded daily for last 3 months was 3.53M.
The market value of RAPT currently stands at $42.65M with its latest stock price at $1.22 and 34.96M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com